Treatment on active surveillance of small renal masses: Progression vs. preference.

ABSTRACT:

Introduction

Active surveillance (AS) of small renal masses (SRM) is increasingly recognized as a safe option. A recent U.S. study found that half of patients receiving treatment on AS were for preference, but these findings may not be generalizable to other jurisdictions and healthcare models. We aimed to investigate AS failure rates and causes among a contemporary biopsy-evaluated cohort in Canada.

Methods

A retrospective review was performed of SRM patients on AS undergoing treatment at our tertiary care center (1999-2018). All patients had undergone renal biopsy and been diagnosed with renal cell carcinoma (RCC). Demographic and clinical parameters surrounding the decision to treat were extracted from chart review. Indications for treatment were dichotomized into clinica

SUBMITTER: Cheung D 

PROVIDER: S-EPMC9054329 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature